Please use this identifier to cite or link to this item: https://dspace.uzhnu.edu.ua/jspui/handle/lib/10463
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAlberto F. Sobrero-
dc.contributor.authorMarc Peeters-
dc.contributor.authorTimothy Jay Price-
dc.contributor.authorYevhen Hotko-
dc.contributor.authorAndres Cervantes-Ruiperez-
dc.contributor.authorMichel Ducreux-
dc.contributor.authorThierry Andre-
dc.contributor.authorEmily Chan-
dc.contributor.authorFlorian Lordick-
dc.contributor.authorYing Tian-
dc.contributor.authorRoger Sidhu-
dc.date.accessioned2016-10-28T07:49:38Z-
dc.date.available2016-10-28T07:49:38Z-
dc.date.issued2012-
dc.identifier.urihttps://dspace.uzhnu.edu.ua/jspui/handle/lib/10463-
dc.language.isoenuk
dc.publisherJ Clin Oncol 30, 2012 (suppl 4; abstr 387)uk
dc.titleFinal results from study 181: Randomized phase III study of FOLFIRI with or without panitumumab (pmab) for the treatment of second-line metastatic colorectal cancer (mCRC)uk
dc.typeTextuk
dc.pubTypeСтаттяuk
Appears in Collections:Наукові публікації кафедри радіології та онкології

Files in This Item:
File Description SizeFormat 
Final_results_from_study_181.PDF255.83 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.